AdvaMed Code of Ethics
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
AdvaMed Best Practice Guidance on Value-Based Arrangements
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
2022 Revised AdvaMed Code Presentation
A comprehensive training deck that companies can pull from depending on the setting and need.
AdvaMed Code Crosswalk
A “Crosswalk” comparing the revised AdvaMed Code with the other codes of ethics, to include: PhRMA; Medtech Europe; and Mecomed.
Medical Education & Training Guidance Document
This Guidance Document provides companies with direction on implementing legitimate, bona fide training and education programs.
Medical Device Mass Tort TV Ad Trends
AdvaMed publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.
SBIR/STTR Information Guides
These guides are for companies interested in non-dilutive funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
AdvaMed Code Of Ethics on Interactions With Health Care Professionals in India
The AdvaMed India Code of Ethics provides medical technology and diagnostics manufacturers with compliance principles and guidance that address the key legal risk areas governing business relationships and activities.
AdvaMed Latin America Priorities Brochure
Medical technologies save and improve the lives of millions of people across Latin America (LatAm) every day, driving economic growth and workforce productivity.